Research shows that many viruses can linger in the air and on surfaces long after an infected person has left the room — ...

Finding rhinoviruses, which cause the common cold, in preserved medical specimens and analysing their RNA genome could let us ...

The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...

We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...

Blood-based biomarker testing might identify patients at increased risk for chronic lung disease following hospitalization for COVID-19.

Clear proof that isolation was the remedy There are a number of proofs (apart from Haygarth’s experiment and Leicester) that it was isolation, not ring vaccination, that eradicated smallpox. First, we ...

A UBC-led team of researchers has discovered two chemical compounds with potent and wide-ranging antiviral activity that ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

Results highlight the possibility of using a blood test to identify people at increased risk of chronic lung disease ...

A growing body of research suggests that everything from the shape of your lungs to how you enunciate your Ts and Ks could ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human animal species. This included many wild animal species as well as domestic ...

The multicenter, double-blinded phase II trial enrolled 448 hospitalized adults with SARS-CoV-2 infection and concomitant hypoxia (peripheral oxygen saturation≤94%) between August 2020 and March 2022.